Certara, Inc. (HAM:700)

Market Cap	712.00M -55.7%
Revenue (ttm)	356.72M +8.7%
Net Income	-1.36M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	11.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	8
Open	4.826
Previous Close	4.603
Day's Range	4.826 - 4.827
52-Week Range	4.603 - 11.625
Beta	n/a
RSI	34.61
Earnings Date	May 5, 2026

About Certara

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scient...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 2008
• Employees: 1,546
• Stock Exchange: Hamburg Stock Exchange
• Ticker Symbol: 700

Financial Performance

In 2025, Certara's revenue was $418.84 million, an increase of 8.75% compared to the previous year's $385.15 million. Losses were -$1.60 million, -86.76% less than in 2024.

Financial numbers in USD